Confidential Enquiry into Maternal Deaths in the UK
| Confidential Enquiry into Maternal Deaths in the UK | |
|---|---|
| [[File:|250px|alt=]] | |
| Formation | 1952 |
| Type | Healthcare |
| Headquarters | United Kingdom |
| Membership | N/A |
| Language | N/A |
| Leader title | N/A |
| Leader name | N/A |
| Website | MBRRACE-UK |
The Confidential Enquiry into Maternal Deaths in the UK (CEMD) is a systematic investigation into the causes and circumstances of maternal deaths in the United Kingdom. Established in 1952, the enquiry aims to improve maternal health outcomes by identifying trends and providing recommendations for healthcare improvements.
History[edit | edit source]
The CEMD was initiated in response to concerns about the high rates of maternal mortality in the UK. Over the years, it has evolved to include a broader scope of maternal health issues, providing valuable insights into the factors contributing to maternal deaths.
Objectives[edit | edit source]
The primary objectives of the CEMD are to:
- Identify the causes of maternal deaths.
- Provide recommendations to improve clinical practice.
- Enhance the quality of maternity care.
- Inform health policy and public health strategies.
Methodology[edit | edit source]
The enquiry collects data from various sources, including hospitals, healthcare professionals, and public health records. Each case of maternal death is reviewed by a panel of experts who assess the circumstances and identify potential areas for improvement.
Impact[edit | edit source]
The findings of the CEMD have led to significant changes in maternity services and clinical guidelines. The recommendations have been instrumental in reducing maternal mortality rates and improving the overall quality of care for pregnant women.
Related Initiatives[edit | edit source]
The CEMD is part of a broader effort to enhance maternal and neonatal health in the UK. It works in conjunction with other initiatives such as the MBRRACE-UK (Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK).
See also[edit | edit source]
External links[edit | edit source]
References[edit | edit source]
MBRRACE-UK Full text,
, Accessed on: 2023-10-01.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
